SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Cash Taxes Paid
SCI Pharmtech Inc
Cash Taxes Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Taxes Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Cash Taxes Paid
NT$72.3m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
7%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Cash Taxes Paid
NT$227.6m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Cash Taxes Paid
NT$153.4m
|
CAGR 3-Years
62%
|
CAGR 5-Years
20%
|
CAGR 10-Years
26%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Cash Taxes Paid
NT$105.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Cash Taxes Paid
NT$915.2m
|
CAGR 3-Years
52%
|
CAGR 5-Years
53%
|
CAGR 10-Years
22%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Cash Taxes Paid
NT$370.9m
|
CAGR 3-Years
40%
|
CAGR 5-Years
19%
|
CAGR 10-Years
18%
|
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Cash Taxes Paid?
Cash Taxes Paid
72.3m
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Cash Taxes Paid amounts to 72.3m TWD.
What is SCI Pharmtech Inc's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 10Y
7%
Over the last year, the Cash Taxes Paid growth was 1 368%. The average annual Cash Taxes Paid growth rates for SCI Pharmtech Inc have been -15% over the past three years , -10% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet